Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Dopacis®

Fluorodopa (18F) 90 MBq/mL solution for injection

Active ingredient

F18-fluorodopa

Disease area

Neurology, Oncology

Available in
, 

Dopacis® in Belgium

Product information
, 

Dopacis® in France

Product information
, 

Dopacis® in International

Product information
, 

Dopacis® in Italy

Product information
, 

Dopacis® in Luxembourg

Product information
, 

Dopacis® in Malta

Product information
, 

Dopacis® in Netherlands

Product information
, 

Dopacis® in Portugal

Product information
, 

Dopacis® in Slovenia

Product information

Dopacis® in Spain

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fluorocholine (18F)

Fluorocholine (18F) CIS bio international 225 MBq/mL solution for injection

Active ingredient

F18-fluorocholine

Disease area

Oncology

Available in
, 

Fluorocholine (18F) in Belgium

Product information
, 

Fluorocholine (18F) in France

Product information
, 

Fluorocholine (18F) in International

Product information
, 

Fluorocholine (18F) in Italy

Product information
, 

Fluorocholine (18F) in Luxembourg

Product information
, 

Fluorocholine (18F) in Malta

Product information
, 

Fluorocholine (18F) in Netherlands

Product information
, 

Fluorocholine (18F) in Portugal

Product information
, 

Fluorocholine (18F) in Slovenia

Product information

Fluorocholine (18F) in Spain

Product information

GalenVita

GalenVita 0.74 –3.70 GBq radionuclide generator

Active ingredient

Germanium (68Ge) chloride / gallium (68Ga) chloride

Disease area

Radionuclide Generators

Available in
, 

GalenVita in Austria

Product information
, 
, 

GalenVita in Bulgaria

Product information
, 

GalenVita in Croatia

Product information
, 

GalenVita in Cyprus

Product information
, 

GalenVita in Czech Republic

Product information
, 

GalenVita in Denmark

Product information
, 

GalenVita in Estonia

Product information
, 

GalenVita in Finland

Product information
, 

GalenVita in France

Product information
, 

GalenVita in Germany

Product information
, 

GalenVita in Greece

Product information
, 

GalenVita in Hungary

Product information
, 

GalenVita in Iceland

Product information
, 

GalenVita in Ireland

Product information
, 

GalenVita in Italy

Product information
, 

GalenVita in Latvia

Product information
, 

GalenVita in Liechestein

Product information
, 

GalenVita in Lithuania

Product information
, 

GalenVita in Luxembourg

Product information
, 

GalenVita in Malta

Product information
, 

GalenVita in Netherlands

Product information
, 

GalenVita in Norway

Product information
, 

GalenVita in Poland

Product information
, 

GalenVita in Portugal

Product information
, 

GalenVita in Romania

Product information
, 

GalenVita in Slovakia

Product information
, 

GalenVita in Slovenia

Product information
, 

GalenVita in Spain

Product information

GalenVita in Sweden

Product information

Gallium (67Ga) Citrate

Gallium Citrate Ga 67 Injection

Active ingredient

Gallium citrate Ga 67

Disease area

Infectious Diseases, Oncology, Pulmonology

Available in
, 

Gallium (67Ga) Citrate in Belgium

Product information
, 
, 

Gallium (67Ga) Citrate in Costa Rica

Product information
, 

Gallium (67Ga) Citrate in Czech Republic

Product information
, 

Gallium (67Ga) Citrate in Denmark

Product information
, 

Gallium (67Ga) Citrate in France

Product information
, 

Gallium (67Ga) Citrate in Greece

Product information
, 

Gallium (67Ga) Citrate in Hungary

Product information
, 

Gallium (67Ga) Citrate in International

Product information
, 

Gallium (67Ga) Citrate in Ireland

Product information
, 

Gallium (67Ga) Citrate in Italy

Product information
, 

Gallium (67Ga) Citrate in Netherlands

Product information
, 

Gallium (67Ga) Citrate in Portugal

Product information
, 

Gallium (67Ga) Citrate in Singapore

Product information
, 

Gallium (67Ga) Citrate in Spain

Product information
, 

Gallium (67Ga) Citrate in United Kingdom

Product information

Gallium (67Ga) Citrate in United States

Product information

Indium (111In) DTPA

Indium (111In) DTPA 37 MBq/mL solution for injection

Active ingredient

In111-pentetate

Disease area

Neurology

Available in
, 

Indium (111In) DTPA in Belgium

Product information
, 

Indium (111In) DTPA in Czech Republic

Product information
, 

Indium (111In) DTPA in Denmark

Product information
, 

Indium (111In) DTPA in Finland

Product information
, 

Indium (111In) DTPA in France

Product information
, 

Indium (111In) DTPA in Germany

Product information
, 

Indium (111In) DTPA in Greece

Product information
, 

Indium (111In) DTPA in Ireland

Product information
, 

Indium (111In) DTPA in Italy

Product information
, 

Indium (111In) DTPA in Netherlands

Product information
, 

Indium (111In) DTPA in Spain

Product information

Indium (111In) DTPA in United Kingdom

Product information

Indium (111In) Oxinate

Indium (111In) oxinate 37 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-oxinate

Disease area

Hematology

Available in
, 

Indium (111In) Oxinate in Belgium

Product information
, 

Indium (111In) Oxinate in Czech Republic

Product information
, 

Indium (111In) Oxinate in Denmark

Product information
, 

Indium (111In) Oxinate in France

Product information
, 

Indium (111In) Oxinate in Germany

Product information
, 

Indium (111In) Oxinate in Italy

Product information
, 

Indium (111In) Oxinate in Netherlands

Product information
, 

Indium (111In) Oxinate in Spain

Product information

Indium (111In) Oxinate in Sweden

Product information

Lutetium-177 chloride

Lutetium (¹⁷⁷Lu) chloride 40 GBq/mL radiopharmaceutical precursor

Active ingredient

Lutetium (¹⁷⁷Lu) chloride

Disease area

Oncology

Available in
, 

Lutetium-177 chloride in Austria

Product information
, 

Lutetium-177 chloride in Belgium

Product information
, 

Lutetium-177 chloride in France

Product information
, 

Lutetium-177 chloride in Germany

Product information
, 

Lutetium-177 chloride in Italy

Product information
, 

Lutetium-177 chloride in Netherlands

Product information
, 

Lutetium-177 chloride in Portugal

Product information
, 

Lutetium-177 chloride in Spain

Product information

Lutetium-177 chloride in Sweden

Product information

MIBG (I123)

MIBG (123.I) 74 MBq/mL solution for injection

Active ingredient

Iobenguane

Disease area

Oncology

Available in
, 

MIBG (I123) in Belgium

Product information
, 

MIBG (I123) in Czech Republic

Product information
, 

MIBG (I123) in Denmark

Product information
, 

MIBG (I123) in Finland

Product information
, 

MIBG (I123) in France

Product information
, 

MIBG (I123) in Germany

Product information
, 

MIBG (I123) in Hungary

Product information
, 

MIBG (I123) in Ireland

Product information
, 

MIBG (I123) in Italy

Product information
, 

MIBG (I123) in Netherlands

Product information
, 

MIBG (I123) in Norway

Product information
, 

MIBG (I123) in Slovakia

Product information
, 

MIBG (I123) in Spain

Product information
, 

MIBG (I123) in Sweden

Product information
, 

MIBG (I123) in Switzerland

Product information

MIBG (I123) in United Kingdom

Product information

Norchol-131

Norchol-131, 7,5 - 15 MBq/mL solution for injection

Active ingredient

Iodomethyl norcholesterol (131I)

Disease area

Nephrology, Oncology

Available in
, 

Norchol-131 in France

Product information
, 

Norchol-131 in International

Product information
, 

Norchol-131 in Italy

Product information

Norchol-131 in Spain

Product information

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Austria

Product information
, 

Octreoscan™ in Belgium

Product information
, 

Octreoscan™ in Czech Republic

Product information
, 

Octreoscan™ in Denmark

Product information
, 

Octreoscan™ in France

Product information
, 

Octreoscan™ in Germany

Product information
, 

Octreoscan™ in Greece

Product information
, 

Octreoscan™ in Hungary

Product information
, 

Octreoscan™ in International

Product information
, 

Octreoscan™ in Ireland

Product information
, 

Octreoscan™ in Italy

Product information
, 

Octreoscan™ in Mexico

Product information
, 

Octreoscan™ in Netherlands

Product information
, 

Octreoscan™ in Portugal

Product information
, 

Octreoscan™ in Republic of Korea

Product information
, 

Octreoscan™ in Singapore

Product information
, 

Octreoscan™ in Slovakia

Product information
, 

Octreoscan™ in Spain

Product information
, 

Octreoscan™ in Sweden

Product information
, 

Octreoscan™ in United Kingdom

Product information

Octreoscan™ in United States

Product information

Pulmocis®

Human albumin as macroaggregates 2 mg, kit for radiopharmaceutical preparation

Active ingredient

macroaggregated human albumin (macrosalb)

Disease area

Pulmonology

Available in
, 

Pulmocis® in Austria

Product information
, 

Pulmocis® in Belgium

Product information
, 

Pulmocis® in Colombia

Product information
, 

Pulmocis® in Croatia

Product information
, 

Pulmocis® in Czech Republic

Product information
, 

Pulmocis® in Denmark

Product information
, 

Pulmocis® in Finland

Product information
, 

Pulmocis® in France

Product information
, 

Pulmocis® in Germany

Product information
, 

Pulmocis® in Greece

Product information
, 

Pulmocis® in International

Product information
, 

Pulmocis® in Ireland

Product information
, 

Pulmocis® in Italy

Product information
, 

Pulmocis® in Luxembourg

Product information
, 

Pulmocis® in Malta

Product information
, 

Pulmocis® in Netherlands

Product information
, 

Pulmocis® in Norway

Product information
, 

Pulmocis® in Portugal

Product information
, 

Pulmocis® in Slovakia

Product information
, 

Pulmocis® in Slovenia

Product information
, 

Pulmocis® in Spain

Product information
, 

Pulmocis® in Sweden

Product information

Pulmocis® in United Kingdom

Product information

PYLCLARI®

PYLCLARI®

Active ingredient

Piflufolastat (18F)

Disease area

Oncology

Available in
, 

PYLCLARI® in Austria

Product information
, 

PYLCLARI® in Bulgaria

Product information
, 

PYLCLARI® in Croatia

Product information
, 

PYLCLARI® in Czech Republic

Product information
, 

PYLCLARI® in Denmark

Product information
, 

PYLCLARI® in Estonia

Product information
, 

PYLCLARI® in Finland

Product information
, 

PYLCLARI® in France

Product information
, 

PYLCLARI® in Germany

Product information
, 

PYLCLARI® in Greece

Product information
, 

PYLCLARI® in Hungary

Product information
, 

PYLCLARI® in Iceland

Product information
, 

PYLCLARI® in Italy

Product information
, 

PYLCLARI® in Latvia

Product information
, 

PYLCLARI® in Lithuania

Product information
, 

PYLCLARI® in Malta

Product information
, 

PYLCLARI® in Netherlands

Product information
, 

PYLCLARI® in Norway

Product information
, 

PYLCLARI® in Poland

Product information
, 

PYLCLARI® in Portugal

Product information
, 

PYLCLARI® in Romania

Product information
, 

PYLCLARI® in Slovakia

Product information
, 

PYLCLARI® in Slovenia

Product information
, 

PYLCLARI® in Spain

Product information

PYLCLARI® in Sweden

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Renocis®

kit for radiopharmaceutical preparation

Active ingredient

Succimer (dimercaptosuccinic acid)

Disease area

Nephrology

Available in
, 

Renocis® in Colombia

Product information
, 

Renocis® in Denmark

Product information
, 

Renocis® in Finland

Product information
, 

Renocis® in France

Product information
, 

Renocis® in Greece

Product information
, 

Renocis® in International

Product information
, 

Renocis® in Ireland

Product information
, 

Renocis® in Italy

Product information
, 

Renocis® in Peru

Product information
, 

Renocis® in Portugal

Product information
, 

Renocis® in Spain

Product information
, 

Renocis® in Sweden

Product information

Renocis® in United Kingdom

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Austria

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Belgium

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Bosnia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Colombia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Costa Rica

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Czech Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Denmark

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Dominican Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Finland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in France

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Germany

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Hungary

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Italy

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Mexico

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Netherlands

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Norway

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Peru

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Portugal

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Serbia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Slovakia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Spain

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Sweden

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Switzerland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Turkey

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Sodium Iodide I123 Injection

Sodium iodide (123I) 37 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I123 Injection in Belgium

Product information
, 

Sodium Iodide I123 Injection in Czech Republic

Product information
, 

Sodium Iodide I123 Injection in Denmark

Product information
, 

Sodium Iodide I123 Injection in Finland

Product information
, 

Sodium Iodide I123 Injection in France

Product information
, 

Sodium Iodide I123 Injection in Germany

Product information
, 

Sodium Iodide I123 Injection in Hungary

Product information
, 

Sodium Iodide I123 Injection in Italy

Product information
, 

Sodium Iodide I123 Injection in Netherlands

Product information
, 

Sodium Iodide I123 Injection in Norway

Product information
, 

Sodium Iodide I123 Injection in Spain

Product information
, 

Sodium Iodide I123 Injection in Sweden

Product information
, 

Sodium Iodide I123 Injection in Switzerland

Product information

Sodium Iodide I123 Injection in United Kingdom

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Australia

Product information
, 

Stamicis® in Austria

Product information
, 

Stamicis® in Belgium

Product information
, 

Stamicis® in Colombia

Product information
, 

Stamicis® in Czech Republic

Product information
, 

Stamicis® in Denmark

Product information
, 

Stamicis® in Finland

Product information
, 

Stamicis® in France

Product information
, 

Stamicis® in Germany

Product information
, 

Stamicis® in Greece

Product information
, 

Stamicis® in India

Product information
, 

Stamicis® in International

Product information
, 

Stamicis® in Ireland

Product information
, 

Stamicis® in Israel

Product information
, 

Stamicis® in Italy

Product information
, 

Stamicis® in Luxembourg

Product information
, 

Stamicis® in Netherlands

Product information
, 

Stamicis® in Norway

Product information
, 

Stamicis® in Peru

Product information
, 

Stamicis® in Portugal

Product information
, 

Stamicis® in Republic of Korea

Product information
, 

Stamicis® in Singapore

Product information
, 

Stamicis® in Slovakia

Product information
, 

Stamicis® in Slovenia

Product information
, 

Stamicis® in Spain

Product information
, 

Stamicis® in Sweden

Product information
, 

Stamicis® in Switzerland

Product information

Stamicis® in United Kingdom

Product information

Striascan™

Striascan 74 MBq/mL solution for injection

Active ingredient

I123-ioflupane

Disease area

Neurology

Available in
, 

Striascan™ in Austria

Product information
, 

Striascan™ in Belgium

Product information
, 

Striascan™ in Bulgaria

Product information
, 

Striascan™ in Croatia

Product information
, 

Striascan™ in Cyprus

Product information
, 

Striascan™ in Czech Republic

Product information
, 

Striascan™ in Denmark

Product information
, 

Striascan™ in Estonia

Product information
, 

Striascan™ in Finland

Product information
, 

Striascan™ in France

Product information
, 

Striascan™ in Germany

Product information
, 

Striascan™ in Greece

Product information
, 

Striascan™ in Hungary

Product information
, 

Striascan™ in Iceland

Product information
, 

Striascan™ in International

Product information
, 

Striascan™ in Ireland

Product information
, 

Striascan™ in Italy

Product information
, 

Striascan™ in Latvia

Product information
, 

Striascan™ in Lithuania

Product information
, 

Striascan™ in Luxembourg

Product information
, 

Striascan™ in Malta

Product information
, 

Striascan™ in Netherlands

Product information
, 

Striascan™ in Norway

Product information
, 

Striascan™ in Poland

Product information
, 

Striascan™ in Portugal

Product information
, 

Striascan™ in Romania

Product information
, 

Striascan™ in Slovakia

Product information
, 

Striascan™ in Slovenia

Product information
, 

Striascan™ in Spain

Product information
, 

Striascan™ in Sweden

Product information
, 

Striascan™ in Switzerland

Product information
, 

Striascan™ in Turkey

Product information

Striascan™ in United Kingdom

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ HDP

(Kit for the Preparation of Technetium Tc 99m Oxidronate Injection)

Active ingredient

Sodium oxidronate

Disease area

Musculoskeletal

Available in
, 

Technescan™ HDP in Austria

Product information
, 

Technescan™ HDP in Belgium

Product information
, 

Technescan™ HDP in Costa Rica

Product information
, 

Technescan™ HDP in Czech Republic

Product information
, 

Technescan™ HDP in Denmark

Product information
, 

Technescan™ HDP in Dominican Republic

Product information
, 

Technescan™ HDP in Finland

Product information
, 

Technescan™ HDP in France

Product information
, 

Technescan™ HDP in Germany

Product information
, 

Technescan™ HDP in Hungary

Product information
, 

Technescan™ HDP in Ireland

Product information
, 

Technescan™ HDP in Italy

Product information
, 

Technescan™ HDP in Moldova

Product information
, 

Technescan™ HDP in Netherlands

Product information
, 

Technescan™ HDP in Norway

Product information
, 

Technescan™ HDP in Peru

Product information
, 

Technescan™ HDP in Portugal

Product information
, 

Technescan™ HDP in Republic of Korea

Product information
, 

Technescan™ HDP in Romania

Product information
, 

Technescan™ HDP in Singapore

Product information
, 

Technescan™ HDP in Slovakia

Product information
, 

Technescan™ HDP in Spain

Product information
, 

Technescan™ HDP in Sweden

Product information
, 

Technescan™ HDP in Switzerland

Product information
, 

Technescan™ HDP in Turkey

Product information

Technescan™ HDP in United Kingdom

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Austria

Product information
, 

Technescan™ MAG3 in Belgium

Product information
, 

Technescan™ MAG3 in Colombia

Product information
, 

Technescan™ MAG3 in Czech Republic

Product information
, 

Technescan™ MAG3 in Denmark

Product information
, 

Technescan™ MAG3 in Finland

Product information
, 

Technescan™ MAG3 in France

Product information
, 

Technescan™ MAG3 in Germany

Product information
, 

Technescan™ MAG3 in Greece

Product information
, 

Technescan™ MAG3 in Hungary

Product information
, 

Technescan™ MAG3 in Ireland

Product information
, 

Technescan™ MAG3 in Italy

Product information
, 

Technescan™ MAG3 in Malaysia

Product information
, 

Technescan™ MAG3 in Mexico

Product information
, 

Technescan™ MAG3 in Netherlands

Product information
, 

Technescan™ MAG3 in Norway

Product information
, 

Technescan™ MAG3 in Peru

Product information
, 

Technescan™ MAG3 in Portugal

Product information
, 

Technescan™ MAG3 in Republic of Korea

Product information
, 

Technescan™ MAG3 in Slovakia

Product information
, 

Technescan™ MAG3 in Spain

Product information
, 

Technescan™ MAG3 in Sweden

Product information
, 

Technescan™ MAG3 in Switzerland

Product information
, 

Technescan™ MAG3 in Turkey

Product information

Technescan™ MAG3 in United Kingdom

Product information

Technescan™ PYP

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Technescan™ PYP in Belgium

Product information
, 

Technescan™ PYP in Colombia

Product information
, 

Technescan™ PYP in Costa Rica

Product information
, 

Technescan™ PYP in Czech Republic

Product information
, 

Technescan™ PYP in Denmark

Product information
, 

Technescan™ PYP in Finland

Product information
, 

Technescan™ PYP in France

Product information
, 

Technescan™ PYP in Germany

Product information
, 

Technescan™ PYP in Hungary

Product information
, 

Technescan™ PYP in Ireland

Product information
, 

Technescan™ PYP in Italy

Product information
, 

Technescan™ PYP in Malaysia

Product information
, 

Technescan™ PYP in Mexico

Product information
, 

Technescan™ PYP in Netherlands

Product information
, 

Technescan™ PYP in Norway

Product information
, 

Technescan™ PYP in Peru

Product information
, 

Technescan™ PYP in Republic of Korea

Product information
, 

Technescan™ PYP in Romania

Product information
, 

Technescan™ PYP in Singapore

Product information
, 

Technescan™ PYP in Spain

Product information
, 

Technescan™ PYP in Sweden

Product information
, 

Technescan™ PYP in Turkey

Product information

Technescan™ PYP in United Kingdom

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Technetium-99m generator

MONTEK 10-40 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Technetium-99m generator in Austria

Product information
, 

Technetium-99m generator in Belgium

Product information
, 

Technetium-99m generator in Bulgaria

Product information
, 

Technetium-99m generator in Denmark

Product information
, 

Technetium-99m generator in France

Product information
, 

Technetium-99m generator in Germany

Product information
, 

Technetium-99m generator in Greece

Product information
, 

Technetium-99m generator in Hungary

Product information
, 

Technetium-99m generator in Italy

Product information
, 

Technetium-99m generator in Netherlands

Product information
, 

Technetium-99m generator in Poland

Product information
, 

Technetium-99m generator in Portugal

Product information
, 

Technetium-99m generator in Romania

Product information

Technetium-99m generator in Spain

Product information

Thallous Chloride Tl 201 Injection

Thallous Chloride Tl 201 Injection

Active ingredient

Tl201-Chloride

Disease area

Cardiology, Endocrinology

Available in
, 

Thallous Chloride Tl 201 Injection in Austria

Product information
, 

Thallous Chloride Tl 201 Injection in Belgium

Product information
, 

Thallous Chloride Tl 201 Injection in Czech Republic

Product information
, 

Thallous Chloride Tl 201 Injection in Denmark

Product information
, 

Thallous Chloride Tl 201 Injection in Finland

Product information
, 

Thallous Chloride Tl 201 Injection in France

Product information
, 

Thallous Chloride Tl 201 Injection in Germany

Product information
, 

Thallous Chloride Tl 201 Injection in Hungary

Product information
, 

Thallous Chloride Tl 201 Injection in Ireland

Product information
, 

Thallous Chloride Tl 201 Injection in Italy

Product information
, 

Thallous Chloride Tl 201 Injection in Netherlands

Product information
, 

Thallous Chloride Tl 201 Injection in Portugal

Product information
, 

Thallous Chloride Tl 201 Injection in Singapore

Product information
, 

Thallous Chloride Tl 201 Injection in Slovakia

Product information
, 

Thallous Chloride Tl 201 Injection in Spain

Product information
, 

Thallous Chloride Tl 201 Injection in Sweden

Product information
, 

Thallous Chloride Tl 201 Injection in Switzerland

Product information
, 

Thallous Chloride Tl 201 Injection in United Kingdom

Product information

Thallous Chloride Tl 201 Injection in United States

Product information

Ultra Technekow™ FM

Ultra-Technekow FM 2.15-43.00 GBq radionuclide generator

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators

Available in
, 

Ultra Technekow™ FM in Austria

Product information
, 

Ultra Technekow™ FM in Belgium

Product information
, 

Ultra Technekow™ FM in Bosnia

Product information
, 

Ultra Technekow™ FM in Colombia

Product information
, 

Ultra Technekow™ FM in Costa Rica

Product information
, 

Ultra Technekow™ FM in Cyprus

Product information
, 

Ultra Technekow™ FM in Czech Republic

Product information
, 

Ultra Technekow™ FM in Denmark

Product information
, 

Ultra Technekow™ FM in Dominican Republic

Product information
, 

Ultra Technekow™ FM in Finland

Product information
, 

Ultra Technekow™ FM in France

Product information
, 

Ultra Technekow™ FM in Germany

Product information
, 

Ultra Technekow™ FM in Greece

Product information
, 

Ultra Technekow™ FM in Hong Kong

Product information
, 

Ultra Technekow™ FM in Hungary

Product information
, 

Ultra Technekow™ FM in India

Product information
, 

Ultra Technekow™ FM in Ireland

Product information
, 

Ultra Technekow™ FM in Italy

Product information
, 

Ultra Technekow™ FM in Luxembourg

Product information
, 

Ultra Technekow™ FM in Malaysia

Product information
, 

Ultra Technekow™ FM in Moldova

Product information
, 

Ultra Technekow™ FM in Netherlands

Product information
, 

Ultra Technekow™ FM in Norway

Product information
, 

Ultra Technekow™ FM in Peru

Product information
, 

Ultra Technekow™ FM in Poland

Product information
, 

Ultra Technekow™ FM in Portugal

Product information
, 

Ultra Technekow™ FM in Republic of Korea

Product information
, 

Ultra Technekow™ FM in Romania

Product information
, 

Ultra Technekow™ FM in Serbia

Product information
, 

Ultra Technekow™ FM in Singapore

Product information
, 

Ultra Technekow™ FM in Slovakia

Product information
, 

Ultra Technekow™ FM in Spain

Product information
, 

Ultra Technekow™ FM in Sweden

Product information
, 

Ultra Technekow™ FM in Switzerland

Product information
, 

Ultra Technekow™ FM in Turkey

Product information

Ultra Technekow™ FM in United Kingdom

Product information

Yttrium 90Y

Yttrium (90Y) citrate CIS bio international 150-370 MBq/mL suspension for intraarticular injection (YMM-1)

Active ingredient

Y90-citrate

Disease area

Rheumatology

Available in
, 

Yttrium 90Y in Belgium

Product information
, 

Yttrium 90Y in Czech Republic

Product information
, 

Yttrium 90Y in France

Product information
, 

Yttrium 90Y in Germany

Product information
, 

Yttrium 90Y in Hungary

Product information
, 

Yttrium 90Y in International

Product information
, 

Yttrium 90Y in Italy

Product information
, 

Yttrium 90Y in Luxembourg

Product information
, 

Yttrium 90Y in Netherlands

Product information
, 

Yttrium 90Y in Slovakia

Product information
, 

Yttrium 90Y in South America

Product information
, 

Yttrium 90Y in Spain

Product information

Yttrium 90Y in Switzerland

Product information